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SCIENTIFIC OPINION 
Scientific Opinion on the substantiation of a health claim related to 
Rosbacher drive
® and increased attention pursuant to 
Article 13(5) of Regulation (EC) No 1924/2006
1 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following an application from Hassia Mineralquellen GmbH & Co KG, submitted for authorisation of a health 
claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the 
EFSA  Panel  on  Dietetic  Products,  Nutrition  and  Allergies  (NDA)  was  asked  to  deliver  an  opinion  on  the 
scientific  substantiation  of  a  health  claim  related  to  Rosbacher  drive
®  and  increased  attention.  The  Panel 
considers  that  Rosbacher  drive
®,  which  contains  natural  mineral  water  plus  grape  juice,  lemon  juice, 
pomegranate juice, elderberry juice, isomaltulose, sucrose, fructose syrup, caffeine, ascorbic acid and natural 
flavourings, is sufficiently characterised. The claimed effect, increased attention, is a beneficial physiological 
effect.  The  single  study  which  was  carried  out  with  Rosbacher  drive
®  was  an  open-label,  non-randomised 
sequential study and the study did not report on any outcomes of attention. No conclusions can be drawn from 
this study for the scientific substantiation of the claim. The Panel concludes that a cause and effect relationship 
has not been established between the consumption of Rosbacher drive
® and increased attention. 
© European Food Safety Authority, 2014 
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SUMMARY 
Following an application from Hassia Mineralquellen GmbH & Co KG, submitted for authorisation of 
a  health  claim  pursuant  to  Article 13(5)  of  Regulation  (EC)  No  1924/2006  via  the  Competent 
Authority of Germany, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was 
asked to deliver an opinion on the scientific substantiation of a health claim related to Rosbacher 
drive
® and increased attention. 
The scope of the application was proposed to fall under a health claim based on newly developed 
scientific evidence. The application included a request for the protection of proprietary data. 
The food that is the subject of the health claim is Rosbacher drive
®, which contains natural mineral 
water plus grape juice (17.5 %), lemon juice (5 %), pomegranate juice (2 %), elderberry juice (0.5 %), 
isomaltulose (30 g/L), sucrose (15 g/L), fructose syrup (10 g/L), caffeine (100 mg/L), ascorbic acid 
(200 mg/L) and natural flavourings. The Panel considers that the food, Rosbacher drive
®, which is the 
subject of the health claim, is sufficiently characterised. 
The claimed effect proposed by the applicant is “maintenance and increase in concentration”. The 
target population proposed by the applicant is “people wishing to support their mental performance”. 
Concentration,  i.e.  attention,  refers  to  the  ability  to  attend  to,  select  and  use  incoming  sensory 
information. Attention is a well-defined construct which can be measured by validated psychometric 
tests. The Panel considers that increased attention is a beneficial physiological effect. 
The applicant identified a total of 31 published studies and one unpublished study as being pertinent to 
the health claim. 
The 31 published studies were not carried out with a food complying with the characterisation of the 
food which is the subject of the claim. The Panel considers that no conclusions can be drawn from 
these studies for the scientific substantiation of the claim. 
Only one study carried out with Rosbacher drive
® was provided. This study was an open-label, non-
randomised sequential study which did not report on any outcomes of attention. The Panel considers 
that no conclusions can be drawn from this study for the scientific substantiation of the claim. 
The  Panel  concludes  that  a  cause  and  effect  relationship  has  not  been  established  between  the 
consumption of Rosbacher drive
® and increased attention. 
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BACKGROUND 
Regulation (EC) No 1924/2006
4 harmonises the provisions that relate to nutrition and health claims, 
and establishes rules governing the Community authorisation of health claims made on foods.  As a 
rule, health claims are prohibited unless they comply with the general and specific requirements of this 
Regulation,  are authorised  in accordance with this Regulation ,  and  are  included in the lists of 
authorised claims provided for in Articles 13 and 14 thereof. In particular,  Article 13(5) of this  
Regulation lays down provisions for the addition of claims (other than those referring to the reduction 
of disease risk and to chi ldren’s  development  and  health)  which  are  based  on  newly  developed 
scientific evidence, or which include a request for the protection of proprietary data, to the Community 
list of permitted claims referred to in Article 13(3). 
According to Article 18 of this Regulation, an application for inclusion in the Community list of 
permitted  claims  referred  to  in  Article 13(3)  shall  be  submitted  by  the  applicant  to  the  national 
competent authority  of a Member  State,  which  will  make  the  application  and  any  supplementary 
information supplied by the applicant available to the European Food Safety Authority (EFSA). 
STEPS TAKEN BY EFSA 
  The application was received on 15/05/2013. 
  The  scope  of  the  application  was  proposed  to  fall  under  a  health  claim  based  on  newly 
developed  scientific  evidence.  The  application  included  a  request  for  the  protection  of 
proprietary data. 
  On 05/07/2013, during the validation process of the application, EFSA sent a request to the 
applicant to provide missing information. 
  On 24/09/2013, EFSA received the missing information as submitted by the applicant. 
  The scientific evaluation procedure started on 10/10/2013. 
  On 22/11/2013, the Working Group on Claims of the NDA Panel agreed on a list of questions 
for the applicant to provide additional information to accompany the application. The clock 
was stopped on 03/12/2013 and restarted on 18/12/2013, in compliance with Article 18(3) of 
Regulation (EC) No 1924/2006. EFSA received the requested information on  24/01/2014, 
beyond the legal deadline (the information was made available to EFSA in electronic format 
on 22/01/2014). 
  During  its  meeting  on  05/02/2014,  the  NDA  Panel,  having  evaluated  the  data  submitted, 
adopted an opinion on the scientific substantiation of a health claim related to Rosbacher 
drive
® and increased attention. 
TERMS OF REFERENCE 
EFSA  is  requested  to  evaluate  the  scientific  data  submitted  by  the  applicant  in  accordance  with 
Article 16(3) of Regulation (EC) No 1924/2006. On the basis of that evaluation, EFSA will issue an 
opinion on the scientific substantiation of a health claim related to: Rosbacher drive
® and increased 
attention. 
EFSA DISCLAIMER 
The present opinion does not constitute, and cannot be construed as, an authorisation for the marketing 
of Rosbacher drive
®, a positive assessment of its safety, nor a decision on whether Rosbacher drive
® 
is, or is not, classified as a foodstuff. It should be noted that such an assessment is not foreseen in the 
framework of Regulation (EC) No 1924/2006. 
                                                       
4  Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and 
health claims made on foods. OJ L 404, 30.12.2006, p. 9–25. Rosbacher drive® and increased attention 
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It should also be highlighted that the scope, the proposed wording of the claim, and the conditions of 
use as proposed by the applicant may be subject to changes, pending the outcome of the authorisation 
procedure foreseen in Article 18(4) of Regulation (EC) No 1924/2006. Rosbacher drive® and increased attention 
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INFORMATION PROVIDED BY THE APPLICANT 
Applicant’s  name  and  address:  Hassia  Mineralquellen  GmbH & Co  KG,  Gießener  Straße 30, 
D-61118 Bad Vilbel, Germany. 
The application includes a request for the protection of proprietary data for one unpublished study 
(Wagner et al., 2007), in accordance with Article 21 of Regulation (EC) No 1924/2006. 
Food/constituent as stated by the applicant 
According to the applicant, the food that is the subject of the health claim is an energy drink marketed 
as Rosbacher drive
® which contains as a basis natural mineral water plus grape juice (17.5 %), lemon 
juice (5 %), pomegranate juice (2 %), elderberry juice (0.5 %), isomaltulose (Palatinose
™, 30 g/L), 
sucrose  (15 g/L),  fructose  syrup  (10 g/L),  caffeine  (100 mg/L),  ascorbic  acid  (200 mg/L)  as 
antioxidant agent and natural flavourings. The carbohydrate content in Rosbacher drive
®, comprising 
sugars from fruit juices and added sugars, was indicated by the applicant as 30 g/L isomaltulose, 
25 g/L glucose and 35 g/L fructose. 
Health relationship as claimed by the applicant 
According  to the  applicant,  the  caffeine,  glucose,  fructose,  sucrose and isomaltulose  contained  in 
Rosbacher drive
® support the intellectual ability/readiness to perform in situations of mental challenge 
[original in German: “fördert die geistige Leistungsbereitschaft bei mentalen Anforderungen”]. 
Wording of the health claim as proposed by the applicant 
The  applicant  proposed  the  following  wording  for  the  health  claim:  “helps/supports/maintains 
concentration” [original in German: “unterstützt die Konzentration”]. 
The following alternative wordings were proposed: “helps/supports/maintains the human ability to 
concentrate”,  “stabilises  concentration”  [originals  in  German:  “unterstützt  die  menschliche 
Konzentrationsfähigkeit”, “stabilisiert die Konzentration”]. 
Specific conditions of use as proposed by the applicant 
The applicant proposed the consumption of 500 mL of Rosbacher drive
® in order to obtain the claimed 
effect. 
The target population is people wishing to support their mental performance in certain situations, e.g. 
during  studies,  professional  activities,  while  driving  car  or  doing  household  chores  [original  in 
German: “wird für Personen/für Lebenssituationen empfohlen, in denen mentale Leistungsfähigkeit 
von Bedeutung ist, wie im Studium, im Beruf, beim Autofahren, im Haushaltsmanagement”]. 
ASSESSMENT 
1.  Characterisation of the food/constituent 
The food that is the subject of the health claim is Rosbacher drive
®, which is marketed as an “energy 
drink”. 
Rosbacher  drive
®  contains  natural  mineral  water  plus  grape  juice  (17.5 %),  lemon  juice  (5 %), 
pomegranate  juice  (2 %),  elderberry  juice  (0.5 %),  isomaltulose  (Palatinose
™,  30 g/L),  sucrose 
(15 g/L), fructose syrup (10 g/L), caffeine (100 mg/L), ascorbic acid (as antioxidant agent, 200 mg/L) 
and natural flavourings. Rosbacher drive
® contains 25 g/L glucose and 35 g/L fructose comprising 
sugars from fruit juices and added sugars. 
Detailed product sheets for the various fruit juices in Rosbacher drive
® were provided. Rosbacher drive® and increased attention 
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The applicant stated that appropriate stability tests were carried out on the product and these tests 
showed compliance with the stability requirements of the product until the “best before” date. 
The Panel considers that the food, Rosbacher drive
®, which is the subject of the health claim, is 
sufficiently characterised. 
2.  Relevance of the claimed effect to human health 
The  applicant  indicated  that  the  proposed  claimed  effect  is  “maintenance  and  increase  in 
concentration”. The target population proposed by the applicant is “people wishing to support their 
mental performance”. 
Concentration,  i.e.  attention,  refers  to  the  ability  to  attend  to,  select  and  use  incoming  sensory 
information  (i.e.  to  concentrate  while  processing  information). There  are  two  broad  categories  of 
attention. Selective attention is the ability to concentrate on one task or source of information to the 
exclusion of others. Sustained attention (vigilance) is the ability to concentrate over a period of time. 
Attention is a well-defined construct which can be measured by validated psychometric tests. 
The Panel considers that increased attention is a beneficial physiological effect. 
3.  Scientific substantiation of the claimed effect 
The applicant performed a literature search in PubMed and Google using the search terms “glucose”, 
“carbohydrate”,  “Palatinose”,  “isomaltulose”,  “caffeine”,  “liquid”,  “dehydration”  and  “fluidity”  in 
combination with “cognition”, “intelligence”, “memory”, “reaction time”, “concentration”, “alertness” 
and “vigilance”. In addition, the applicant searched for pertinent studies in literature lists of CIAA 
(Confederation  of  food  and  drink  industries  of  Europe),  ERNA  (European  Responsible  Nutrition 
Alliance), EHPM (European Federation of Associations of Health Product Manufacturers) and EBF 
(European Botanical Forum). Studies were included if they were carried out in humans and assessed 
the effects of hydration, caffeine, carbohydrates/glucose, or a combination of these, on the ability to 
concentrate. 
The Panel notes that a health claim on caffeine and increased attention has already been assessed with 
a favourable outcome (EFSA NDA Panel, 2011), and that the conditions of use for that claim were set 
at  75 mg  caffeine  per  serving.  The  Panel  also  notes  that  with  respect  to  the  health  claim  under 
evaluation  the  consumption  of  500 mL  of  Rosbacher  drive
®  (as  proposed  by  the  applicant  as 
conditions of use for the claim) would lead to an intake of 50 mg caffeine. 
The applicant identified a total of 31 published studies and one unpublished study as being pertinent to 
the health claim. 
The 31 published studies were carried out with caffeine (17 studies), carbohydrates or isomaltulose 
(nine studies),  and  various  combinations  of  caffeine  plus  carbohydrates  (four studies).  One  study 
assessed the effect of dehydration on mental function. The Panel notes that these studies were not 
carried out with a food which complies with the specifications indicated in section 1 and considers that 
no conclusions can be drawn from these studies for the scientific substantiation of the claim. 
Only one study (Wagner et al., 2007, unpublished, claimed as proprietary by the applicant) was carried 
out with Rosbacher drive
®. This study was an open-label, non-randomised sequential study in 10 male 
students.  The  primary  outcome  was  alertness  as  measured  by  a  self-rated  questionnaire 
(“Alertometer”). The Panel notes that the primary outcome of the study was a subjective measure of 
alertness, which cannot be used as a measure of attention (EFSA NDA Panel, 2012). A number of 
other outcomes were provided which did not assess attention. The Panel considers that no conclusions 
can be drawn from this study for the scientific substantiation of the claim. 
The  Panel  concludes  that  a  cause  and  effect  relationship  has  not  been  established  between  the 
consumption of Rosbacher drive
® and increased attention. Rosbacher drive® and increased attention 
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CONCLUSIONS 
On the basis of the data presented, the Panel concludes that: 
  The  food,  Rosbacher  drive
®,  which  is  the  subject  of  the  health  claim,  is  sufficiently 
characterised. 
  The claimed effect proposed by the applicant is “maintenance and increase in concentration”. 
The target population proposed by the applicant is “people wishing to support their mental 
performance”. Increased attention is a beneficial physiological effect. 
  A  cause  and  effect  relationship  has  not  been  established  between  the  consumption  of 
Rosbacher drive
® and increased attention. 
DOCUMENTATION PROVIDED TO EFSA 
Health claim application on Rosbacher drive
® and increased attention pursuant to Article 13(5) of 
Regulation  (EC)  No  1924/2006  (Claim  serial  No:  0382_DE).  May  2013.  Submitted  by  Hassia 
Mineralquellen GmbH & Co KG. 
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